Related Experiment Videos
Juvenile type of chronic myeloid leukaemia in a four year old boy
M el Mauhoub1, G Sudarshan, R Baloch
1El Fatah Childrens' Hospital, University of Garyounis, Benghazi, S.P.L.A.J.
Insights
Childhood chronic myeloid leukaemia (CML) is a rare and aggressive cancer. Juvenile CML has a poor prognosis, with a mean survival of only 9 months, and current treatments show limited benefit.
Area of Science:
- Pediatric Hematology Oncology
- Leukemia Research
- Childhood Cancer Studies
Background:
- Chronic myeloid leukaemia (CML) is a rare hematologic malignancy affecting children.
- Three distinct subtypes of CML exist in childhood: juvenile (infantile), adult, and familial types.
- All childhood CML subtypes present with a uniformly poor prognosis, necessitating urgent research into effective therapies.
Observation:
- Juvenile CML, a specific subtype, has a particularly grim outlook with a mean survival of approximately 9 months.
- The adult variant of CML in children shows some response to therapy but ultimately leads to fatal blast crisis.
- Current treatment modalities for juvenile CML have demonstrated limited efficacy, highlighting a critical unmet need.
Findings:
- This report details a case of juvenile CML in a four-year-old boy exhibiting characteristic clinical and laboratory findings.
- The case presentation underscores the aggressive nature and poor prognosis associated with juvenile CML.
- The patient's presentation aligns with established literature on the distinct features of this rare childhood leukemia.
Implications:
- The uniformly poor prognosis of childhood CML emphasizes the urgent need for novel therapeutic strategies.
- Further research into the pathophysiology and treatment of juvenile CML is crucial for improving patient outcomes.
- This case report contributes to the limited body of literature on juvenile CML, aiding in clinical understanding and future research directions.
Abstract:
Chronic myeloid leukaemia (CML) is a rare disease in children. Three varieties of CML occur in childhood. Juvenile (Infantile), adult and familial types, each with distinct clinical and laboratory findings. Prognosis of all these types of CML in childhood is uniformly bad. The mean survival of a juvenile CML is 9 months and that of adult variety is 2.5 years. The adult form of childhood CML responds to therapy, but the patient succumbs to the disease during the blast crisis. Various modalities of treatments are being tried in the juvenile CML without any beneficial effect. We report a case of juvenile CML with characteristic findings in a four year old boy.